Preclinical efficacy studies in investigator brochures: Do they enable risk–benefit assessment?
Table 2
Reporting on internal, construct, and external validity items on the preclinical efficacy study (PCES) level and the investigator brochure (IB) level.
doi: https://doi.org/10.1371/journal.pbio.2004879.t002